Tumor-derived CCL2/5 are significant indicators of early relapse and infiltration of TAMs, which contribute to cancer cell proliferation, inflammatory microenvironment of tumors, immune response evasion and angiogenesis [27, 28]. The gene discussed is CCL2; the disease is cancer.